World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
27139
World Ranking
2273
National Ranking
1102

Overview

Sijy O'Dell is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily focuses on medicine and immunology and microbiology, with significant contributions to infectious diseases, virology, molecular biology, immunology, and radiology, nuclear medicine and imaging.

The scientist's main areas of study revolve around topics such as HIV research and treatment, SARS-CoV-2 and COVID-19 research, monoclonal and polyclonal antibodies research, vaccines and immunoinformatics approaches, animal virus infections studies, immunotherapy and immune responses, and viral gastroenteritis research and epidemiology.

Sijy O'Dell has contributed publications to a range of scientific venues, frequently publishing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • New England Journal of Medicine
  • Cell Reports
  • Nature Communications
  • UNC Libraries

Their recent papers include the following:

  • "An mRNA Vaccine against SARS-CoV-2 - Preliminary Report," 2020, New England Journal of Medicine
  • "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults," 2020, New England Journal of Medicine
  • "Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates," 2020, New England Journal of Medicine
  • "Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination," 2020, New England Journal of Medicine
  • "Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19," 2021, New England Journal of Medicine

Frequently collaborating with other researchers, Sijy O'Dell's co-authors include:

  • Nicole A. Doria-Rose
  • John R. Mascola
  • Peter D. Kwong
  • Adrian B. McDermott
  • Stephen D. Schmidt

Best Publications

  • An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman

  • Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    John R. Mascola;Gary Nabel;Barton F. Haynes;Xueling Wu

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.

    Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell

  • Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.

    Pegu, Amarendra, O’Connell, Sarah E.;Stephen D. Schmidt;O’Dell, Sijy, Talana, Chloe A.

  • Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

    Katharine J Bar;Michael C Sneller;Linda J Harrison;J Shawn Justement

  • Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

    Mattia Bonsignori;Kwan Ki Hwang;Xi Chen;Chun Yen Tsao

  • Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    Rebecca M. Lynch;Eli Boritz;Emily E. Coates;Adam DeZure

  • Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies

    Nicole A. Doria-Rose;Rachel M. Klein;Maura M. Manion;Sijy O'Dell

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    Young Do Kwon;Marie Pancera;Priyamvada Acharya;Ivelin S. Georgiev

  • Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables

    Nicole A. Doria-Rose;Rachel M. Klein;Marcus G. Daniels;Sijy O'Dell

  • Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.

    Lei Chen;Young Do Kwon;Tongqing Zhou;Xueling Wu

  • Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    Rui Kong;Kai Xu;Tongqing Zhou;Priyamvada Acharya

  • mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    Unknown

  • Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

    Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  • Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    Rebecca S. Rudicell;Young Do Kwon;Sung-Youl Ko;Amarendra Pegu

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Richard T. Wyatt
Richard T. Wyatt Scripps Research Institute
Krisha McKee
Krisha McKee National Institute of Allergy and Infectious Diseases
Nicole A. Doria-Rose
Nicole A. Doria-Rose National Institute of Allergy and Infectious Diseases
Mark K. Louder
Mark K. Louder National Institute of Allergy and Infectious Diseases
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Gwo-Yu Chuang
Gwo-Yu Chuang Moderna Therapeutics (United States)
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to various healthcare careers that are in high demand. Many students complement their Immunology studies with practical nursing credentials to enhance their skills and job prospects. For those interested in nursing, there are several accessible pathways, such as the easiest accelerated nursing programs to get into, which allow students to fast-track their Bachelor of Science in Nursing (BSN).

If you prefer a more focused nursing role, exploring easy LPN programs to get into can provide a solid foundation in patient care without extensive time commitments. For those aiming for advanced clinical roles, the easiest online nurse practitioner programs offer flexible options that combine convenience with quality education.

Specializing further in mental health nursing is possible through pmhnp programs online with best clinical placement, which provide excellent opportunities for hands-on clinical experience and job placement. These diverse online degree options create pathways that align well with Immunology, enabling graduates to impact patient care and research effectively.

Best Scientists Citing Sijy O'Dell

Trending Scientists

Recently Published Articles